Monday morning pre-market screamer 😱 candidates: 🚨🚨🚨💎💎💎🔥🔥🔥 $TCBP Phase 2 update still pending-huge potential on this nano float $BOXD over $1 easy $ALLR PT $.50 $HTGM she’s ready for another big run This week was very good to me.

SIMILAR SETUP TO $AMAM, $HTGM, $APVO, $APCX Volume increasing since last week ✅ Low float recent IPO ✅ Strong future trial pipeline ✅ Time for the next leg up towards IPO price!

SHOULD be some awesome opportunities this week, study study study!

$ATNM positive news in their acute myeloid leukemia trials 👇🏼 53% 1-year Overall Survival and 32% 2-year Overall Survival are approximately double outcomes with current approaches It's time to get in before we blast off to $12+ next!

Anyway, since this trial is expensive and yet necessary for regulatory approval; I interpret it as a bullish signal.

2023 is going to be highlighted with a continuous cascade of amazingly positive PR’s confirming the fact (already documented in 300+ early clinical studies), that Rencofilstat is truly a Wonder Drug to be celebrated, with an extraordinarily large TAM.

$HEPA Was hoping we would get an update on our (Nash) trial soon and we got this surprising good news.

I didnt sell a share and with stellar results for this soon to be released study it should gain traction well over 3 imo.

We knows recession is coming next year 4) XBI has bottomed and should begin its upward move next year 5) Phase 2b trial results and updates on HCC trial 6) Probable approvals of NASH drugs and increased bullish sentiment in the sector

Sign up for the free trial, it's easy.

button for good trial results in the NASH space.

Highly statistically significant results because of the large trial size.

At 🌋 phase.

$BBAI They have to factor in the jobs report which was excellent as well, it means that AI isn't going to phase out a key aspect of the economy.